Insider Selling: Penumbra (NYSE:PEN) EVP Sells 600 Shares of Stock

Key Points

• Penumbra, Inc. EVP Johanna Roberts sold 600 shares of stock on October 1st at an average price of $249.70, totaling $149,820, reducing her position by 0.93% to 64,257 shares.
• Penumbra's stock increased by 1.0% recently, closing at $256.05, while the company reported quarterly earnings of $0.86 EPS, exceeding analysts' expectations.
• Analyst ratings for Penumbra show a consensus of "Moderate Buy" with an average target price of $302.93, and multiple firms have set price targets above $290.

Penumbra, Inc. (NYSE:PEN - Get Free Report) EVP Johanna Roberts sold 600 shares of the stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $249.70, for a total value of $149,820.00. Following the completion of the transaction, the executive vice president owned 64,257 shares in the company, valued at approximately $16,044,972.90. The trade was a 0.93% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Johanna Roberts also recently made the following trade(s):

• On Tuesday, September 2nd, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $270.58, for a total value of $162,348.00.
• On Monday, August 11th, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $238.94, for a total value of $143,364.00.

Penumbra Stock Up 1.0%

NYSE:PEN traded up $2.56 on Friday, hitting $256.05. The stock had a trading volume of 362,538 shares, compared to its average volume of 442,705. The business's fifty day moving average is $257.64 and its 200 day moving average is $262.97. The company has a market cap of $9.99 billion, a PE ratio of 68.10, a P/E/G ratio of 2.29 and a beta of 0.41. The company has a quick ratio of 4.04, a current ratio of 6.75 and a debt-to-equity ratio of 0.02. Penumbra, Inc. has a 52 week low of $190.08 and a 52 week high of $310.00.

Penumbra (NYSE:PEN - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.05. Penumbra had a return on equity of 11.55% and a net margin of 11.54%.The business had revenue of $339.46 million for the quarter, compared to analyst estimates of $327.37 million. During the same quarter in the prior year, the company earned $0.64 earnings per share. The company's quarterly revenue was up 13.4% on a year-over-year basis. Penumbra has set its FY 2025 guidance at EPS. On average, equities research analysts expect that Penumbra, Inc. will post 3.67 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently commented on the company. Truist Financial set a $310.00 price target on Penumbra and gave the stock a "buy" rating in a report on Wednesday, July 30th. Wells Fargo & Company set a $290.00 price target on Penumbra in a report on Wednesday. Royal Bank Of Canada dropped their price target on Penumbra from $330.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Morgan Stanley lifted their price target on Penumbra from $260.00 to $266.00 and gave the stock an "equal weight" rating in a report on Thursday, July 31st. Finally, Canaccord Genuity Group set a $350.00 price target on Penumbra and gave the stock a "buy" rating in a report on Wednesday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Penumbra currently has a consensus rating of "Moderate Buy" and an average target price of $302.93.

Hedge Funds Weigh In On Penumbra

Hedge funds have recently made changes to their positions in the stock. Wealth Enhancement Advisory Services LLC increased its stake in Penumbra by 74.7% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,115 shares of the company's stock worth $740,000 after acquiring an additional 1,332 shares during the last quarter. Merit Financial Group LLC bought a new position in Penumbra in the 1st quarter worth about $207,000. UMB Bank n.a. increased its stake in Penumbra by 110.4% in the 1st quarter. UMB Bank n.a. now owns 404 shares of the company's stock worth $108,000 after acquiring an additional 212 shares during the last quarter. Portside Wealth Group LLC increased its stake in Penumbra by 10.1% in the 1st quarter. Portside Wealth Group LLC now owns 2,288 shares of the company's stock worth $612,000 after acquiring an additional 210 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its stake in Penumbra by 606.3% in the 1st quarter. Farther Finance Advisors LLC now owns 445 shares of the company's stock worth $121,000 after acquiring an additional 382 shares during the last quarter. 88.88% of the stock is currently owned by hedge funds and other institutional investors.

Penumbra Company Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.